{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:38:45Z","timestamp":1778215125975,"version":"3.51.4"},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2023,12,1]]},"DOI":"10.5551\/jat.64118","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T22:12:31Z","timestamp":1687299151000},"page":"1917-1926","source":"Crossref","is-referenced-by-count":4,"title":["<i>JAK2<\/i> V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms"],"prefix":"10.5551","volume":"30","author":[{"given":"Naoki","family":"Oyama","sequence":"first","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keito","family":"Doyu","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Miyazato","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideho","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Yagita","sequence":"additional","affiliation":[{"name":"Department of Stroke Medicine, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR and Cancer Genome P: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 2005; 365: 1054-1061","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Rumi E and Cazzola M: Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms. Blood, 2017; 129: 680-692","DOI":"10.1182\/blood-2016-10-695957"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Nagai K, Shimoyama T, Yamaguchi H, Sakamoto Y, Suda S, Wakita S, Nishiyama Y, Inokuchi K and Kimura K: Clinical characteristics and brain MRI findings in myeloproliferative neoplasms. J Neurol Sci, 2020; 416: 116990","DOI":"10.1016\/j.jns.2020.116990"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kato Y, Hayashi T, Sehara Y, Deguchi I, Fukuoka T, Maruyama H, Horiuchi Y, Nagamine Y, Sano H and Tanahashi N: Ischemic stroke with essential thrombocythemia: a case series. J Stroke Cerebrovasc Dis, 2015; 24: 890-893","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Posfai E, Marton I, Szoke A, Borbenyi Z, Vecsei L, Csomor A and Sas K: Stroke in essential thrombocythemia. J Neurol Sci, 2014; 336: 260-262","DOI":"10.1016\/j.jns.2013.10.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Matsuura S, Thompson CR, Belghasem ME, Bekendam RH, Piasecki A, Leiva O, Ray A, Italiano J, Yang M, Merill-Skoloff G, Chitalia VC, Flaumenhaft R and Ravid K: Platelet Dysfunction and Thrombosis in JAK2(V617F)-Mutated Primary Myelofibrotic Mice. Arterioscler Thromb Vasc Biol, 2020; 40: e262-e272","DOI":"10.1161\/ATVBAHA.120.314760"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wang W, Liu W, Fidler T, Wang Y, Tang Y, Woods B, Welch C, Cai B, Silvestre-Roig C, Ai D, Yang YG, Hidalgo A, Soehnlein O, Tabas I, Levine RL, Tall AR and Wang N: Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2 (V617F) Mice. Circ Res, 2018; 123: e35-e47","DOI":"10.1161\/CIRCRESAHA.118.313283"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, Liu W, Thomas DG, Hajebrahimi MA, Pircher J, Silvestre-Roig C, Kotini AG, Luchsinger LL, Wei Y, Westerterp M, Snoeck HW, Papapetrou EP, Schulz C, Massberg S, Soehnlein O, Ebert B, Levine RL, Reilly MP, Libby P, Wang N and Tall AR: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis. Nature, 2021; 592: 296-301","DOI":"10.1038\/s41586-021-03341-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dotan I, Yang J, Ikeda J, Roth Z, Pollock-Tahiri E, Desai H, Sivasubramaniyam T, Rehal S, Rapps J, Li YZ, Le H, Farber G, Alchami E, Xiao C, Karim S, Gronda M, Saikali MF, Tirosh A, Wagner KU, Genest J, Schimmer AD, Gupta V, Minden MD, Cummins CL, Lewis GF, Robbins C, Jongstra-Bilen J, Cybulsky M and Woo M: Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux. Commun Biol, 2022; 5: 132","DOI":"10.1038\/s42003-022-03078-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL and Marsh EE, 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993; 24: 35-41","DOI":"10.1161\/01.STR.24.1.35"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kondo T, Okuno N, Naruse H, Kishimoto M, Tasaka T, Tsujioka T, Matsuoka A, Sugihara T, Tohyama Y and Tohyama K: Validation of the revised 2008 WHO diagnostic criteria in 75 suspected cases of myeloproliferative neoplasm. Leuk Lymphoma, 2008; 49: 1784-1791","DOI":"10.1080\/10428190802258972"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tanashyan MM, Kuznetsova PI, Shabalina AA, Raskurazhev AA, Lagoda OV, Subortseva IN and Melikyan AL: Clinical Characteristics of Cerebrovascular Pathology with Patients Suffering from Ph-Negative Myeloproliferative Disease. Cerebrovasc Dis Extra, 2016; 6: 66-70","DOI":"10.1159\/000448597"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Barbui T, Finazzi G, Carobbio A, Thiele J, Passamonti F, Rumi E, Ruggeri M, Rodeghiero F, Randi ML, Bertozzi I, Gisslinger H, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A, Vannucchi AM and Tefferi A: Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood, 2012; 120: 5128-5133; quiz 5252","DOI":"10.1182\/blood-2012-07-444067"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hobbs CM, Manning H, Bennett C, Vasquez L, Severin S, Brain L, Mazharian A, Guerrero JA, Li J, Soranzo N, Green AR, Watson SP and Ghevaert C: JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia. Blood, 2013; 122: 3787-3797","DOI":"10.1182\/blood-2013-06-501452"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hekimoglu H, Toprak SF and Sozer S: JAK2V617F-Positive Endothelial Cells Induce Apoptosis and Release JAK2V617F-Positive Microparticles. Turk J Haematol, 2022; 39: 13-21","DOI":"10.4274\/tjh.galenos.2021.2021.0607"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Banerjee C and Chimowitz MI: Stroke Caused by Atherosclerosis of the Major Intracranial Arteries. Circ Res, 2017; 120: 502-513","DOI":"10.1161\/CIRCRESAHA.116.308441"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang Y, Meng R, Liu G, Cao C, Chen F, Jin K, Ji X and Cao G: Intracranial atherosclerotic disease. Neurobiol Dis, 2019; 124: 118-132","DOI":"10.1016\/j.nbd.2018.11.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Masuoka T, Hayashi N, Hori E, Kuwayama N, Ohtani O and Endo S: Distribution of internal elastic lamina and external elastic lamina in the internal carotid artery: possible relationship with atherosclerosis. Neurol Med Chir (Tokyo), 2010; 50: 179-182","DOI":"10.2176\/nmc.50.179"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Sun R, Xiao L and Duan S: High expression of ubiquitin conjugates and NF-kappaB in unstable human intracranial atherosclerotic plaques. J Cell Physiol, 2012; 227: 784-788","DOI":"10.1002\/jcp.22790"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ogata J, Yonemura K, Kimura K, Yutani C and Minematsu K: Cerebral infarction associated with essential thrombocythemia: an autopsy case study. Cerebrovasc Dis, 2005; 19: 201-205","DOI":"10.1159\/000083877"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Zhou J, Li YS and Chien S: Shear stress-initiated signaling and its regulation of endothelial function. Arterioscler Thromb Vasc Biol, 2014; 34: 2191-2198","DOI":"10.1161\/ATVBAHA.114.303422"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bai X, Fu M, Li Z, Gao P, Zhao H, Li R and Sui B: Distribution and regional variation of wall shear stress in the curved middle cerebral artery using four-dimensional flow magnetic resonance imaging. Quant Imaging Med Surg, 2022; 12: 5462-5473","DOI":"10.21037\/qims-22-67"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Stefanou MI, Richter H, Hartig F, Wang Y, Orgel A, Bender B, Mengel A, Ziemann U and Poli S: Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms. Eur J Neurol, 2019; 26: 903-e964","DOI":"10.1111\/ene.13907"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, McConkey M, Gupta N, Gabriel S, Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S and Ebert BL: Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med, 2017; 377: 111-121","DOI":"10.1056\/NEJMoa1701719"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Misaka T, Kimishima Y, Yokokawa T, Ikeda K and Takeishi Y: Clonal hematopoiesis and cardiovascular diseases: role of JAK2V617F. J Cardiol, 2022;","DOI":"10.1016\/j.jjcc.2022.02.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bhattacharya R, Zekavat SM, Haessler J, Fornage M, Raffield L, Uddin MM, Bick AG, Niroula A, Yu B, Gibson C, Griffin G, Morrison AC, Psaty BM, Longstreth WT, Bis JC, Rich SS, Rotter JI, Tracy RP, Correa A, Seshadri S, Johnson A, Collins JM, Hayden KM, Madsen TE, Ballantyne CM, Jaiswal S, Ebert BL, Kooperberg C, Manson JE, Whitsel EA, Program NT-OfPM, Natarajan P and Reiner AP: Clonal Hematopoiesis Is Associated With Higher Risk of Stroke. Stroke, 2022; 53: 788-797","DOI":"10.1161\/STROKEAHA.121.037388"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Ong E, Barraco F, Nighoghossian N, Praire A, Desestret V, Derex L, Vighetto A and Biotti D: Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm. Rev Neurol (Paris), 2016; 172: 703-708","DOI":"10.1016\/j.neurol.2016.09.010"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Kim JM, Jung KH and Park KY: Radiological features and outcomes of essential thrombocythemia-related stroke. J Neurol Sci, 2019; 398: 135-137","DOI":"10.1016\/j.jns.2019.01.035"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_64118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T04:34:23Z","timestamp":1701491663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/30\/12\/30_64118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64118","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"article-number":"64118"}}